Status:
UNKNOWN
β-cell Function and Insulin Sensitivity in Patients With Cystic Fibrosis
Lead Sponsor:
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Conditions:
Cystic Fibrosis-related Diabetes
Eligibility:
All Genders
18-45 years
Brief Summary
Cystic fibrosis is a genetic disorder caused by mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene, leading to pulmonary infections, sinus disease, pancreatic insufficien...
Detailed Description
The study aims are: * Task 1: pathophysiological characterization of CFRD with assessment of the relative contribution of the insulin resistance and the β-cellular secretion impairment through the us...
Eligibility Criteria
Inclusion
- written informed
- diagnosis of cystic fibrosis
Exclusion
- celiac disease
- pregnancy
- diagnosis of T1DM
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2023
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04379726
Start Date
July 1 2020
End Date
September 1 2023
Last Update
May 7 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.